InvestorsHub Logo
Followers 2
Posts 223
Boards Moderated 0
Alias Born 10/01/2018

Re: Sam81 post# 189850

Friday, 05/03/2019 5:58:47 AM

Friday, May 03, 2019 5:58:47 AM

Post# of 426609
Thank you Sam. I must admit that I look forward to seeing the numbers you provide albeit with trepidation now. We no longer have the first quarter to use as a reason for not seeing the hockey stick in sales. We did not have a short week, spring break is over, the sales force has been in the field and contacted the target physicians multiple times. I now believe that we will not see a serious ramp up in sales until after FDA approval and direct to consumer advertising begins. I also find the lack of a European submission very puzzling. We know that we are dealing with a limited time of exclusivity. Every day that Amarin does not submit a European application diminishes the value to shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News